Corbus Pharmaceuticals

(NASDAQ) CRBP

Current Price$10.47

Market Cap$204.36M

Since IPO (2014)-88%

5 Year-78%

1 Year+53%

1 Month+10%

Corbus Pharmaceuticals Financials at a Glance

Market Cap

$204.36M

Revenue (TTM)

$0.00

Net Income (TTM)

$84.53M

EPS (TTM)

$-5.81

P/E Ratio

-1.90

Dividend

$0.00

Beta (Volatility)

1.24 (Average)

Dividend

$0.00

Beta (Volatility)

1.24 (Average)

Price

$10.47

Volume

4,735

Open

$11.06

Price

$10.47

Volume

4,735

Open

$11.06

Previous Close

$11.03

Daily Range

$10.39 - $11.06

52-Week Range

$6.72 - $20.56

Dividend

$0.00

Beta (Volatility)

1.24 (Average)

Price

$10.47

Volume

4,735

Open

$11.06

Previous Close

$11.03

Daily Range

$10.39 - $11.06

52-Week Range

$6.72 - $20.56

CRBP News

3 Stocks Robinhood Investors Love

Will HealyAug 16, 2020

Better Buy: GW Pharmaceuticals vs. Corbus Pharmaceuticals

Sushree MohantyJul 17, 2020

Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Corbus Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Yuval Cohen, PhD

Website

www.corbuspharma.com

Headquarters

Norwood, MA 02062, US

CRBP Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-67%

Return on Capital

-71%

Return on Assets

-59%

Earnings Yield

-52.63%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$204.36M

Shares Outstanding

18.53M

Volume

4.74K

Avg. Volume

247.90K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$85.31M

EBITDA

$78.30M

Operating Cash Flow

$64.49M

Capital Expenditure

$7.00K

Free Cash Flow

$64.50M

Cash & ST Invst.

$163.94M

Total Debt

$1.63M

Corbus Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$49.00K

+99.7%

Gross Margin

0.00%

N/A

Market Cap

$204.36M

N/A

Market Cap/Employee

$7.30M

N/A

Employees

N/A

Net Income

$22.97M

-35.3%

EBITDA

$24.30M

-30.8%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$137.40M

+5.7%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$1.21M

-27.0%

Return on Assets

-58.50%

N/A

Return on Invested Capital

-71.11%

N/A

Free Cash Flow

$25.58M

-55.8%

Operating Cash Flow

$25.57M

-55.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

IPHAInnate Pharma S.A.

IPHAInnate Pharma S.A.$2.23+10.40%

ELTXElicio Therapeutics, Inc.

ELTXElicio Therapeutics, Inc.$9.75-8.23%

ALECAlector, Inc.

ALECAlector, Inc.$2.15-0.46%

MOLNMolecular Partners AG

MOLNMolecular Partners AG$3.70-3.65%

MISTMilestone Pharmaceuticals Inc.

MISTMilestone Pharmaceuticals Inc.$1.49-1.00%

FBRXForte Biosciences, Inc.

FBRXForte Biosciences, Inc.$21.02-9.06%

CRDFCardiff Oncology, Inc.

CRDFCardiff Oncology, Inc.$1.65-1.32%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.30-0.05%

AIIORobo.ai

AIIORobo.ai$5.70+0.42%

TET1 Energy Inc.

TET1 Energy Inc.$6.64+0.17%

INTCIntel

INTCIntel$106.37-0.02%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$43.32-0.03%

NVDANvidia

NVDANvidia$221.66-0.02%

POETPoet Technologies

POETPoet Technologies$13.77-0.14%

Questions About CRBP

What is the current price of Corbus Pharmaceuticals?

Corbus Pharmaceuticals is trading at $10.47 per share.

What is the 52-week range for Corbus Pharmaceuticals?

Over the past 52 weeks, Corbus Pharmaceuticals has traded between $6.72 and $20.56.

How much debt does Corbus Pharmaceuticals have?

As of the most recent reporting period, Corbus Pharmaceuticals reported total debt of $1.21M.

How much cash does Corbus Pharmaceuticals have on hand?

Corbus Pharmaceuticals reported $26.05M in cash and cash equivalents in its most recent financial results.

What is Corbus Pharmaceuticals’s dividend yield?

Corbus Pharmaceuticals does not currently have a dividend yield.

Corbus Pharmaceuticals

Corbus Pharmaceuticals Financials at a Glance

CRBP News

Corbus (CRBP) Q2 Loss Beats Estimates

This Biotech Penny Stock Is Better Than Dogecoin

Why Corbus Pharmaceuticals Is Getting Slammed Today

2 Dirt-Cheap Robinhood Stocks That Could Skyrocket

3 Awful Stocks Robinhood Investors Love -- and 1 of the Best

Robinhood Investors Love These 3 Biotech Stocks. Should You?

3 Stocks Robinhood Investors Love

Better Buy: GW Pharmaceuticals vs. Corbus Pharmaceuticals

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Corbus Pharmaceuticals

CRBP Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Corbus Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CRBP

What is the current price of Corbus Pharmaceuticals?

What is the 52-week range for Corbus Pharmaceuticals?

How much debt does Corbus Pharmaceuticals have?

How much cash does Corbus Pharmaceuticals have on hand?

What is Corbus Pharmaceuticals’s dividend yield?

Premium Investing Services